Face to Face Hot Stocks: Teladoc Health, Inc. (NYSE:TDOC), Xylem Inc. (NYSE:XYL)

Teladoc Health, Inc. (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) closed at $232.3 on the last trading session with an decrease of -2.01%, whereas, it previously closed at $237.07. The company has a market capitalization of $19.28 Billion. The company traded shares of 1.03 Million on the trading day while its three month average volume stands at 2.66 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Teladoc Health, Inc. (NYSE:TDOC) produced diluted EPS of -1.36. The EPS estimate for next year as estimated by analysts is at -0.59 while EPS for next quarter is estimated at -0.24. Earnings per Share growth for this year is reported at 6.7, while the analysts estimated the EPS growth for next year at -0.59% and Earnings growth for next 5 years stands at 20% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 33.1%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Teladoc Health, Inc. (NYSE:TDOC) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Teladoc Health, Inc. (NYSE:TDOC) stands at 31.84 and Price to Book or P/B for the most recent quarter stands at 17.37. The Price to Free Cash Flow ratio or P/FCF is reported at 700.95. The quick ratio and the current ratio of Teladoc Health, Inc. (NYSE:TDOC) are reported at 6.1 and 6.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Teladoc Health, Inc. (NYSE:TDOC) stands at -6.2, -9.8 and -4.8 respectively

The trailing twelve month Revenue of Teladoc Health, Inc. (NYSE:TDOC) is reported at 605.5 Million with income of -98300000. The outstanding shares of Teladoc Health, Inc. (NYSE:TDOC) are 82.61 Million. The institutional Ownership of the shares of 99.3 stands at 0.80%, this figure is increased 3.03 in the last six months. The insider ownership for the shares of Teladoc Health, Inc. (NYSE:TDOC) is ticked at 1%, the figure is plummeted -38.5% in the last six months.

Some other important financial aspects to be discussed here for Teladoc Health, Inc. (NYSE:TDOC) is the Mean Target Price estimated by the analysts which stands at 188. The 52 week high of Teladoc Health, Inc. (NYSE:TDOC) is placed at 239.44 and 52 week low is standing at 54.58.

Performance wise the shares of Teladoc Health, Inc. (NYSE:TDOC) rose up 7.82% for the week, it also rise 24.22% for the monthly performance, while for the quarter it went down 44.04%. The shares increase 126.32% for the half year and flew up for the Year-To-Date performance. The shares of Teladoc Health, Inc. (NYSE:TDOC) grew 247.41% for the yearly performance.

Xylem Inc. (NYSE:XYL)

Xylem Inc. (NYSE:XYL) closed at $73.41 on the last trading session with an decrease of -1.69%, whereas, it previously closed at $74.67. The company has a market capitalization of $13.5 Billion. The company traded shares of 191351 on the trading day while its three month average volume stands at 1.34 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Xylem Inc. (NYSE:XYL) produced diluted EPS of 1.99. The EPS estimate for next year as estimated by analysts is at 2.65 while EPS for next quarter is estimated at 0.25. Earnings per Share growth for this year is reported at -28, while the analysts estimated the EPS growth for next year at 2.65% and Earnings growth for next 5 years stands at 12% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 3.9%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Xylem Inc. (NYSE:XYL) is at 37.58 while the forward p/e is at 28.21. The P/S or Price to Sales ratio of Xylem Inc. (NYSE:XYL) stands at 2.63 and Price to Book or P/B for the most recent quarter stands at 4.79. The Price to Free Cash Flow ratio or P/FCF is reported at 36.68. The quick ratio and the current ratio of Xylem Inc. (NYSE:XYL) are reported at 1.2 and 1.6 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Xylem Inc. (NYSE:XYL) stands at 4.7, 12.5 and 9 respectively

The trailing twelve month Revenue of Xylem Inc. (NYSE:XYL) is reported at 5.14 Billion with income of 360 Million. The outstanding shares of Xylem Inc. (NYSE:XYL) are 180.2 Million. The institutional Ownership of the shares of 93.2 stands at 0.80%, this figure is decreased -0.1 in the last six months. The insider ownership for the shares of Xylem Inc. (NYSE:XYL) is ticked at 0.4%, the figure is plummeted -8.37% in the last six months.

Some other important financial aspects to be discussed here for Xylem Inc. (NYSE:XYL) is the Mean Target Price estimated by the analysts which stands at 69.64. The 52 week high of Xylem Inc. (NYSE:XYL) is placed at 89.34 and 52 week low is standing at 54.62.

Performance wise the shares of Xylem Inc. (NYSE:XYL) rose up 0.08% for the week, it also rise 14.95% for the monthly performance, while for the quarter it went down 3.85%. The shares decrease -10.75% for the half year and plummeted for the Year-To-Date performance. The shares of Xylem Inc. (NYSE:XYL) shrinked -7% for the yearly performance.